LOR-253 HCl
253-SOL1-01
Phase 1 small_molecule completed
Quick answer
LOR-253 HCl for Advanced or Metastatic Solid Tumours is a Phase 1 program (small_molecule) at Aptose Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Aptose Biosciences
- Indication
- Advanced or Metastatic Solid Tumours
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed